Tag: remdesivir

WHO Says No to Remdesivir as COVID-19 Treatment

By Robert Preidt HealthDay Reporter FRIDAY, Nov. 20, 2020 (HealthDay News) — The antiviral drug remdesivir is not recommended for hospitalized COVID-19 patients because...

FDA Authorizes Arthritis Drug Combo for COVID-19

Nov. 19, 2020 — The FDA on Thursday granted emergency use authorization for the arthritis drug baricitinib to be used in combination with remdesivir to...

74 and overweight, Donald Trump faces extra risks from ‘a very sneaky virus’

By Sheryl Gay Stolberg WASHINGTON: President Donald Trump, like many men in his 70s, has mild heart disease. He takes a statin drug to treat...

Russia to supply Avifavir drug to 17 nations for coronavirus treatment

NEW DELHI: The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ChemRar Group have agreed to supply Avifavir, the world’s first registered favipiravir-based...

COVID-19: Various measures taken to ensure availability of essential drugs, says gov

New Delhi: The government has taken “timely and effective” measures to tackle any possible disruptions in supply of essential drugs during the COVID-19 pandemic and...

Remdesivir sold at high prices in Mumbai black market; some doctors suggest cheaper alternatives

Mumbai: A black market has sprung up in Mumbai for the antiviral Remdesivir prescribed for the treatment of Covid-19, with some doctors pointing out that...

Covid-19: Central drugs regulator asks states, UTs to prevent black marketing of Remdesivir | India News

NEW DELHI: India’s drugs regulator has asked drug controllers in states and Union territories to keep a strict vigil to prevent black marketing of the...

remdesivir: Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per vial

NEW DELHI: Pharmaceutical major Mylan NV on Monday said it has received approval from Indian drugs regulator DCGI to manufacture and market its remdesivir for...

remdesivir: Remdesivir shortage in Maharashtra public hospitals

Mumbai: Public hospitals in Maharashtra, the state with the highest number of active Covid-19 cases, are facing a shortage of Remdesivir because the local authorities...

favipiravir: Glenmark launches Favipiravir: Medics say ‘no magic bullet’ for COVID but will help amid rising cases

New Delhi: As Glenmark Pharmaceuticals launched antiviral drug Favipiravir for the treatment of mild to moderate COVID-19 cases, medical experts on Saturday cautioned against seeing...

Combination Drug Therapy For COVID Treatment

By Dennis Thompson HealthDay Reporter THURSDAY, May 21, 2020 (HealthDay News) — A combination drug therapy for COVID-19 aims to both prevent...

​US pharma firm Gilead Sciences likely to seek nod to market anti-viral drug remdesivir in India

NEW DELHI: US pharmaceutical giant Gilead Sciences is likely to apply to India’s Central Drugs Standard Control Organisation (CDSCO) soon seeking marketing authorisation for its...

Remdesivir expected to be available for COVID-19 patients from next week: top company official

HOUSTON: Antiviral drug Remdesivir, approved by the US food and regulatory body for emergency use to treat the COVID-19 patients, is expected to be available...

Trump says evidence ties China lab to virus, threatens tariffs

WASHINGTON: US President Donald Trump on Thursday threatened China with fresh tariffs as he stepped up his attacks on Beijing over the coronavirus crisis, saying...

Remdesivir & COVID Studies Find Different Results

“For example, the primary end point of the NIAID-designed trial was met and will provide more information on the benefit of the drug,” Adalja concluded....

Company says drug proved effective against virus in US study

WASHINGTON: A biotech company said Wednesday its experimental drug has proved effective against the new coronavirus in a major US government study that put it...

Good News on Remdesivir’s Power to Treat COVID-19

By Robert Preidt HealthDay Reporter TUESDAY, April 21, 2020 (HealthDay News) — Preliminary data from two clinical trials using the antiviral drug remdesivir to treat...

Remdesivir Might Be a Good Bet Against COVID-19

THURSDAY, April 16, 2020 (HealthDay News) — New research sheds light on why the experimental drug remdesivir might become the most powerful weapon in the...